BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35974233)

  • 21. Unexplained increases in serum carcinoembryonic antigen levels in colorectal cancer patients during the postoperative follow-up period: an analysis of its incidence and longitudinal pattern.
    Nozawa H; Yokota Y; Emoto S; Yokoyama Y; Sasaki K; Murono K; Abe S; Sonoda H; Shinagawa T; Ishihara S
    Ann Med; 2023; 55(2):2246997. PubMed ID: 37963211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma.
    Veingerl B
    Wien Klin Wochenschr; 2001; 113 Suppl 3():32-8. PubMed ID: 15503618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prothrombin time (PT) and CEA as prognostic predictive biomarkers for postoperative recurrence after curative resection in patients with stage I-III colorectal cancer: a retrospective cohort study.
    Ma L; Li W; Liu N; Ding Z; Cai J; Zhang Y
    Updates Surg; 2022 Jun; 74(3):999-1009. PubMed ID: 35322387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer.
    Sonoda H; Yamada T; Matsuda A; Ohta R; Shinji S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kuriyama S; Miyasaka T; Yoshida H
    Eur J Surg Oncol; 2021 Nov; 47(11):2880-2887. PubMed ID: 34103245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of postoperative CEA for surveillance of recurrence after resection of primary colorectal cancer.
    Bhatti I; Patel M; Dennison AR; Thomas MW; Garcea G
    Int J Surg; 2015 Apr; 16(Pt A):123-128. PubMed ID: 25771102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carcinoembryonic antigen and patterns of recurrence after curative resection of the colorectal cancer.
    Park JY; Lee KH
    Hepatogastroenterology; 2007; 54(79):1966-9. PubMed ID: 18251140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of postoperative serum level of carcinoembryonic antigen (CEA) and actual half life of CEA in colorectal cancer patients.
    Choi JS; Min JS
    Yonsei Med J; 1997 Feb; 38(1):1-7. PubMed ID: 9100477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carcinoembryonic antigen elevation in post-hepatectomy patients with colorectal cancer liver metastasis indicates recurrence with high accuracy.
    Hara M; Sato M; Takahashi H; Takayama S; Okada Y; Nagasaki T; Takeyama H
    Hepatogastroenterology; 2013; 60(128):1935-9. PubMed ID: 24719930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrence after complete cryoablation of colorectal liver metastases: analysis of prognostic features.
    Yan TD; Nunn DR; Morris DL
    Am Surg; 2006 May; 72(5):382-90. PubMed ID: 16719189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors predicting long-term survival in colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.
    Huh JW; Kim CH; Lim SW; Kim HR; Kim YJ
    J Cancer Res Clin Oncol; 2013 Sep; 139(9):1449-55. PubMed ID: 23765330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postoperative carcinoembryonic antigen level has a prognostic value for distant metastasis and survival in rectal cancer patients who receive preoperative chemoradiotherapy and curative surgery: a retrospective multi-institutional analysis.
    Jeong S; Nam TK; Jeong JU; Kim SH; Kim K; Jang HS; Jeong BK; Lee JH
    Clin Exp Metastasis; 2016 Dec; 33(8):809-816. PubMed ID: 27553616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
    Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
    Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of postoperative carcinoembryonic antigen concentration and extent of invasion of resection margins after hepatic resection for colorectal metastases.
    Gervaz P; Blanchard A; Pampallona S; Mach JP; Fontolliet C; Gillet M
    Eur J Surg; 2000 Jul; 166(7):557-61. PubMed ID: 10965835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative CA19-9: a competitive predictor of recurrence in patients with colorectal cancer liver metastases after hepatectomy.
    Liu JM; Wang YY; Liu W; Xu D; Wang K; Xing BC
    Int J Colorectal Dis; 2021 Apr; 36(4):767-778. PubMed ID: 33420522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of the Postoperative Carcinoembryonic Antigen Level during Follow-Up after Curative Resection in Patients with Liver Metastatic Colorectal Carcinoma.
    Hashimoto T; Itabashi M; Ogawa S; Hirosawa T; Bamba Y; Kaji S; Ubukata M; Shimizu S; Sugihara K; Kameoka S
    Hepatogastroenterology; 2014 Jun; 61(132):989-93. PubMed ID: 26158154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases.
    Kumar Y; Pinedo IR; Tapuria N; Zabron A; Davidson BR
    Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1006-11. PubMed ID: 18787469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aggressive recurrences determine oncologic outcomes after resection of liver metastases from primary right colon cancer: Results of a case-control study.
    Zimmitti G; Panettieri E; Ardito F; Mele C; Maria V; Rosso E; Nuzzo G; Giuliante F
    Eur J Surg Oncol; 2021 Apr; 47(4):834-841. PubMed ID: 33032866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic features and oncologic outcomes of colorectal cancer patients with extremely high carcinoembryonic antigen.
    Lee SY; Jo JS; Kim HJ; Kim CH; Ju JK; Kim YJ; Kim HR
    Int J Colorectal Dis; 2015 Jan; 30(1):63-9. PubMed ID: 25367182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors and time-related changes influence results of colorectal liver metastases surgical treatment: a single-center analysis.
    Martí J; Modolo MM; Fuster J; Comas J; Cosa R; Ferrer J; Molina V; Romero J; Fondevila C; Charco R; García-Valdecasas JC
    World J Gastroenterol; 2009 Jun; 15(21):2587-94. PubMed ID: 19496187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.